Immunovia AB (publ) (IMMNOV.ST) Financials

IMMNOV.ST Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 65.7 million 19.2 million
Dec. 31, 2025 88.2 million 23.5 million
Sept. 30, 2025 37.7 million 45.9 million
June 30, 2025 34.8 million 17.1 million

IMMNOV.ST Free Cash Flow and Stock based compensation

No data available :(

IMMNOV.ST Net Income

No data available :(

IMMNOV.ST Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 56.1 million - -
Dec. 31, 2025 77.5 million - 857000
Sept. 30, 2025 26.6 million - -
June 30, 2025 29.3 million - -

IMMNOV.ST Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 672.7 million
Dec. 31, 2025 529.2 million
Sept. 30, 2025 383.0 million
June 30, 2025 297.8 million

IMMNOV.ST Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - - - -
Dec. 31, 2025 5.6 million 4.3 million -4.3 million -
Sept. 30, 2025 5.6 million - 10.0 million -
June 30, 2025 - 6.9 million 19.8 million -

IMMNOV.ST Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 374000 18.0 million
Dec. 31, 2025 354000 16.6 million
Sept. 30, 2025 101000 36000
June 30, 2025 90000 13.0 million

IMMNOV.ST

Price: SEK0.20

52 week price:
0.15
0.75

Earnings Per Share: -0.26 SEK

Exchange: STO

Sector: Healthcare

Industry: Diagnostics & Research

Market Capitalization: 127.3 million

Links: